Search Within

Brian Kushner

  1. "2016"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Neuroblastoma Service (11)
  2. Pediatrics, Department of (11)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (8)
  5. GSK Faculty (8)
  6. Tow Center for Developmental Oncology (TCDO) (8)

More Groups

People
  1. Shakeel Modak (9)
  2. Nai-Kong Cheung (8)
  3. Kim Kramer (5)
  4. Michael La Quaglia (5)
  5. Stephen Roberts (5)
  6. Suzanne Wolden (5)

More People

Years
  1. 2016 (11)
Publications
  1. Journal of Clinical Oncology (3)
  2. Pediatric Blood and Cancer (3)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Nuclear Medicine (1)
  5. Journal of Pediatric Surgery (1)
  6. Oncotarget (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Wiley Periodicals, Inc (3)
  3. Elsevier Inc. (2)
  4. Impact Journals (1)
  5. Society of Nuclear Medicine (1)
  6. W.B. Saunders Co-Elsevier Inc. (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB)
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Leyco, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of arsenic trioxide in neuroblastoma and other paediatric solid tumors
    Meeting Abstract

    Kudva, A.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Local control with 21-Gy radiation therapy for high-risk neuroblastoma
    Meeting Abstract

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; LaQuaglia, M.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Local control with 21-Gy radiation therapy for high-risk neuroblastoma
    Journal Article

    Casey, D. L.; Kushner, B. H.; Cheung, N. K. V.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2016)

    Fulltext@MSK | Save
  • Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study
    Meeting Abstract

    Friedman, D. N.; Wolden, S. L.; Antal, Z.; Moskowitz, C. S.; Hilden, P.; Cheung, N. K. V.; Kushner, B. H.; Tonorezos, E. S.; Carlow, D.; Oeffinger, K. C.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Short-interval retreatment with stereotactic body radiotherapy (SBRT) for pediatric neuroblastoma resulting in severe myositis
    Journal Article

    Taunk, N. K.; Kushner, B.; Ibanez, K.; Wolden, S. L.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Salvage rates after progression of high-risk neuroblastoma with a soft tissue mass
    Journal Article

    Murphy, J. M.; Lim, I. I. P.; Farber, B. A.; Heaton, T. E.; Basu, E. M.; Roberts, S. S.; Modak, S.; Kushner, B. H.; LaQuaglia, M. P.
    Journal of Pediatric Surgery (2016)

    Fulltext@MSK | Save
  • Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
    Journal Article

    Kushner, B. H.; Ostrovnaya, I.; Cheung, I. Y.; Kuk, D.; Modak, S.; Kramer, K.; Roberts, S. S.; Basu, E. M.; Yataghene, K.; Cheung, N. K. V.
    Oncotarget (2016)

    Fulltext@MSK | Save